Found Tirzepatide Review 2026

Almost every provider in this category treats insurance as irrelevant because compounded medication is never covered. Found found the part that is coverable — the clinician — and built its model on it.

Compounded tirzepatide is $289 a month standard, with medication included and the price flat at every dose. Choose the insurance route and the first month is $149; commit to a twelve-month plan and the rate drops to $179.

What insurance is actually paying for is the visit. With insurance you get a synchronous video visit with a board-certified clinician, billed through your plan at your usual copay — Found cites roughly $30. Self-pay care is chat or text-based at a flat monthly price with no separate visit copay. Same clinicians either way; only the format changes.

The supply chain is the strongest part

Found states it partners exclusively with 503A-licensed compounding pharmacies, describes that as the most rigorously regulated tier, and notes that those facilities must comply with USP standards for sterile preparation while compounding against an individual prescription. Every batch is third-party tested for potency, purity and sterility before shipping.

That is more than CoreAge Rx, Mochi, Eden or Measured disclose — none of them names its pharmacy tier or commits to batch testing in writing. For tirzepatide specifically, where you are buying a molecule nobody has approved in that form, knowing who prepared it and what was tested is worth real money.

Where the price lands

Against the all-in field — CoreAge Rx at $129, Mochi at $169, Fridays at $198, Measured at $268, Eden at $298 — Found's $289 standard sits second from the top. The twelve-month rate of $179 is competitive, but committing a year before you know how you tolerate the drug is the same trap that makes Lemonaid's prepayment discounts risky.

The 16% average weight loss Found advertises is self-reported member data as of February 2026, not a trial result, and the company labels it as such.

What compounded tirzepatide actually is

Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.

Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.

Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.

Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.

Before you buy from anyone

1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
5. Ask whether a refund is available if a provider declines to prescribe.
6. Tell the prescriber every medication and supplement you take, including anything bought online.